Potential mechanisms causing delayed effects of respiratory syncytial virus infection.
Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College School of Medicine at St. Mary's, London, United Kingdom. p.openshaw@ic.ac.uk
P J
PJ
Openshaw
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use; D001249:Asthma / Q000276:immunology / Q000517:prevention & control / Q000821:virology*; D001990:Bronchiolitis, Viral / Q000150:complications / Q000276:immunology* / Q000821:virology*; D004195:Disease Models, Animal; D006801:Humans; D007114:Immunization; D007223:Infant; D051379:Mice; D000069455:Palivizumab; D011657:Pulmonary Eosinophilia / Q000276:immunology / Q000821:virology; D018357:Respiratory Syncytial Virus Infections / Q000150:complications / Q000235:genetics / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab